BPG is committed to discovery and dissemination of knowledge
Featured Articles
4/30/2015 9:45:00 AM | Browse: 641 | Download: 1293
Publication Name World Journal of Stem Cells
Manuscript ID 14372
Country France
Received
2014-09-30 08:40
Peer-Review Started
2014-10-01 11:47
To Make the First Decision
2014-10-28 14:34
Return for Revision
2014-10-30 18:32
Revised
2014-11-13 20:51
Second Decision
2014-12-23 20:12
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-12-31 13:44
Articles in Press
2014-12-31 13:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-03-31 09:58
Publish the Manuscript Online
2015-04-23 12:08
ISSN 1948-0210 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cell Biology
Manuscript Type Review
Article Title Use of human pluripotent stem cells to study and treat retinopathies
Manuscript Source Invited Manuscript
All Author List Karim Ben M’Barek, Florian Regent and Christelle Monville
Funding Agency and Grant Number
Corresponding Author Christelle Monville, PhD, INSERM UMR861, I-Stem, AFM, 5 rue Henri Desbruères, Genopole Campus 1, 91030 Evry, France. cmonville@istem.fr
Key Words Drug screening; Human pluripotent stem cells; Disease modeling; Retinitis pigmentosa
Core Tip Human pluripotent stem cells (hPSCs) are usually evoked for their potential for regenerative medicine. However, beside these aspects, novel interests raise from the potential of hPSCs to model human diseases including retinopathies. In this review, we describe how these cells allow the study of the molecular mechanisms leading to some form of retinopathies through the development of retinal specific cell type derived from the differentiation of hPSCs. We also discuss the use of hPSCs cellular models for the validation of gene therapy and for drug screening purpose.
Publish Date 2015-04-23 12:08
Citation Ben M’Barek K, Regent F, Monville C. Use of human pluripotent stem cells to study and treat retinopathies. World J Stem Cells 2015; 7(3): 596-604
URL http://www.wjgnet.com/1948-0210/full/v7/i3/596.htm
DOI http://dx.doi.org/10.4252/wjsc.v7.i3.596
Full Article (PDF) WJSC-7-596.pdf
Full Article (Word) WJSC-7-596.doc
Manuscript File 14372-Review.docx
Answering Reviewers 14372-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form 14372-Conflict-of-i nterest statement.pdf
Copyright License Agreement 14372-Copyright assignment.pdf
Peer-review Report 14372-Peer review(s).pdf
Scientific Misconduct Check 14372-CrossCheck.jpg
Scientific Editor Work List 14372-Scientific editor work list.pdf